EUVIMEDEUVIMED entdecken
QuerschnittstudieOpen Access · CC BY 4.0

EQ-5D-5L Measurement in Bulgarian Community Pharmacies: A Cross-Sectional Study of Published Patient Data and a New Pharmacist Survey to Inform a Prospective Feasibility Study

Yoanna Vutova, Svetlin Georgiev, Hristo Krastev, Georgi Slavchev, Slaveyko Djambazov

Pharmacy · 12.11.2026 · 14 (8) · 171

DOI: 10.3390/pharmacy14080171 ↗

Kurz gefasst

Querschnittstudie in der Zeitschrift Pharmacy, online erschienen am 12.11.2026. Verfasst von Yoanna Vutova und 4 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Bulgaria lacks routine EQ-5D-5L data collection and a national value set, so domestic health technology assessment relies on imported utility values. This study evaluated whether existing evidence justifies a feasibility study of routine EQ-5D-5L measurement in community pharmacies. In this cross-sectional study, reported according to STROBE, we analysed secondary data from a previously published pharmacy-based patient survey and primary data from a new pharmacist survey on questionnaire-based mental health screening, and used both to specify its design. In the source study (n = 119), complete EQ-5D-5L data were obtained from all enrolled participants (mean utility 0.72, 95% CI 0.679–0.756), with directionally consistent known-groups differences; the number of patients approached, administration time and acceptability were not reported. Among surveyed pharmacists (n = 105; convenience sample, response rate not calculable), 80.0% would undertake training and 75.2% would participate in a screening service given clear referral procedures; leading constraints were lack of confidential space (79.0%), time (64.8%) and trained staff (56.2%). Familiarity with PHQ-9/GAD-7 was associated with greater willingness (risk difference 20.5 percentage points, 95% CI 3.9–35.9). EQ-5D-5L-specific readiness was not assessed. Because key feasibility parameters are unknown, a prospective multicentre feasibility study is justified; its endpoints and provisional progression criteria are specified.

Zitieren

APA

Vutova, Y., Georgiev, S., Krastev, H., Slavchev, G., & Djambazov, S. (2026). EQ-5D-5L Measurement in Bulgarian Community Pharmacies: A Cross-Sectional Study of Published Patient Data and a New Pharmacist Survey to Inform a Prospective Feasibility Study. Pharmacy, 14(8), 171. https://doi.org/10.3390/pharmacy14080171

Vancouver

Vutova Y, Georgiev S, Krastev H, Slavchev G, Djambazov S. EQ-5D-5L Measurement in Bulgarian Community Pharmacies: A Cross-Sectional Study of Published Patient Data and a New Pharmacist Survey to Inform a Prospective Feasibility Study. Pharmacy. 2026;14(8):171. doi:10.3390/pharmacy14080171

BibTeX
@article{Vutova2026,
  author = {Vutova, Yoanna and Georgiev, Svetlin and Krastev, Hristo and Slavchev, Georgi and Djambazov, Slaveyko},
  title = {EQ-5D-5L Measurement in Bulgarian Community Pharmacies: A Cross-Sectional Study of Published Patient Data and a New Pharmacist Survey to Inform a Prospective Feasibility Study},
  journal = {Pharmacy},
  year = {2026},
  volume = {14},
  number = {8},
  pages = {171},
  doi = {10.3390/pharmacy14080171}
}
Kostenlos starten →